Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Selective serotonin reuptake inhibitors for major depression.
D002170:Canada; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D016527:Drug Costs; D006077:Government Agencies; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D013673:Technology Assessment, Biomedical
D017367:Selective Serotonin Reuptake Inhibitors